Pioneering transformational drug discovery and development in the areas of cancer and fibrosis
RXC004 – Clinical Phase 1 study ongoing
Pioneering transformational drug discovery and development in the areas of cancer and fibrosis
GI-targeted ROCK – Potential first-in-class for Crohn’s Disease

Drug discovery and development business creating high value cancer and fibrosis therapeutics